Physician

Lawrence Stone Mcgee, MD

According to 2025 Medicare claims, Lawrence Mcgee, MD (NPI: 1124008644) practices nephrology in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF SPARTANBURG, LLC (NPI: 1437108461; TIN: 204485213) and primary practice location at 29307-1017.

Mcgee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 1,870 HCPCS/CPT codes, and received $271,968 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,370 prescription claims across 376 beneficiaries totaling $709,909 in drug costs, led by Samsca (Tolvaptan). DME data shows 11 claims. Open Payments data shows 69 records totaling $1,462. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $337,451 and ending at $271,968. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $572,292 and ending at $709,909. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	655	3,222	$337,451
2016	571	2,584	$275,225
2017	533	2,626	$251,430
2018	508	2,568	$253,499
2019	479	2,010	$226,734
2020	431	1,660	$193,632
2021	334	1,460	$212,367
2022	300	2,366	$387,240
2023	253	1,782	$301,276
2024	227	1,870	$271,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	423	4,565	$572,292
2016	392	4,251	$593,317
2017	360	3,702	$808,867
2018	328	3,155	$964,097
2019	306	2,851	$504,723
2020	285	2,529	$391,180
2021	266	1,984	$273,134
2022	348	2,147	$320,826
2023	367	2,296	$415,275
2024	376	2,370	$709,909

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	139	$8,815
2016	N/R	61	$3,279
2017	N/R	115	$4,531
2018	N/R	153	$7,193
2019	N/R	137	$5,189
2020	N/R	146	$3,622
2021	N/R	148	$3,372
2022	N/R	121	$2,048
2023	N/R	60	$872
2024	N/R	11	$169

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	121	777	$257
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	94	185	$211
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	238	$82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	70	133	$12
90970	Dialysis services, per day, less than full month service (20 years or older)	22	473	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Samsca	Tolvaptan	11	326	$319,473
Auryxia	Ferric Citrate	56	2,106	$95,130
Tolvaptan	Tolvaptan	19	550	$59,828
Veltassa	Patiromer Calcium Sorbitex	42	1,436	$37,249
Lokelma	Sodium Zirconium Cyclosilicate	55	1,770	$32,202

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$169

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,462	AKEBIA THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lawrence Stone Mcgee, MD?

Tedicare shows public-source Medicare data for Lawrence Stone Mcgee, MD (NPI 1124008644), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lawrence Stone Mcgee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lawrence Stone Mcgee, MD?

Lawrence Stone Mcgee, MD is linked to NEPHROLOGY ASSOCIATES OF SPARTANBURG, LLC (billing NPI 1437108461) in the available physician profile data.

Does Lawrence Stone Mcgee, MD have Open Payments data?

Lawrence Stone Mcgee, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.